Pfizer Limited has informed the Exchange regarding a press release dated August 11, 2025, titled "Pfizer Launches 20-valent Pneumococcal Conjugate Vaccine (PCV20) for Adults in India, Offering Broad Protection Against Pneumococcal Disease".
Press Release Aug 11 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Pfizer
- Draft Annual Return 2024-25
- Pfizer: Audited Results - Year ended March 31, 2025
- Pfizer: Unaudited Results – Quarter ended December 31, 2024
- Pfizer: Integrated filing (Financial) for the quarter ended December 31, 2024
- Annual Return 2023-24
Later from Pfizer
- Pfizer: Unaudited Results – Quarter Ended June 30, 2025
- Annual Return – 2024-25
- Pfizer: & Cipla Announce Exclusive Marketing and Distribution Partnership for Select Brands in India
- Press Release Dec 19 2025
- Pfizer: Unaudited Results – Quarter ended December 31, 2025
Follow Pfizer into a list and get an email when it puts out news.
Follow Pfizer